Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Journal of Immunology Research|August 25, 2020
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® ProteinsEmelie Foord, Charlotte Klynning, Esther Schoutrop, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Iscience|December 25, 2024
Single cell profiling of hematopoietic stem cell transplant recipients reveals TGF-β1 and IL-2 confer immunoregulatory functions to NK cellsJessica A Mathews, Dorota T Borovsky, Kyle T Reid, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Transplantation|March 15, 2006
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centerOlle Ringdén, Mats Remberger, Britt-Marie Svahn, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Journal of Immunology Research|August 25, 2020
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® ProteinsEmelie Foord, Charlotte Klynning, Esther Schoutrop, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Iscience|December 25, 2024
Single cell profiling of hematopoietic stem cell transplant recipients reveals TGF-β1 and IL-2 confer immunoregulatory functions to NK cellsJessica A Mathews, Dorota T Borovsky, Kyle T Reid, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Transplantation|March 15, 2006
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centerOlle Ringdén, Mats Remberger, Britt-Marie Svahn, et al.
Pageof 26